HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activity.
S D Young, L S Payne, W J Thompson, N Gaffin, T A Lyle, S F Britcher, S L Graham, T H Schultz, A A Deana, P L Darke
Index: J. Med. Chem. 35 , 1702, (1992)
Full Text: HTML
Abstract
A systematic investigation was undertaken to determine the role of the P1' sidechain in a series of hydroxyethylene isostere based inhibitors of HIV-1 protease. Substitution and homologation of the benzyl P1' side chain of the Phe-Phe isostere based pseudo peptides 1 (L-682,679) and 2 (L-685,434) with various heteroalkyl groups leads to a series of extremely potent inhibitors of the enzyme. Several examples of the most potent inhibitors were very effective in an ex vivo cell based viral spread assay using human H9 T-lymphocytes and the IIIb isolate of HIV-1. Compound 19 is 120 times more potent than 1 and 16 times more potent than 2 in inhibiting the spread of infection in this assay.
Related Compounds
Related Articles:
1992-07-10
[J. Med. Chem. 35 , 2525, (1992)]
1992-05-15
[J. Med. Chem. 35 , 1685, (1992)]
1993-04-16
[J. Med. Chem. 36 , 941, (1993)]
D'Aniello, F. et al.
[J. Org. Chem. 59 , 3762, (1994)]
Dorsey, B.D. et al.
[Tetrahedron Lett. 34 , 1851, (1993)]